DBV Technologies S.A. Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff

DBV Technologies (NASDAQ:DBVT) craters 45% premarket on increased volume in reaction to its announcement that the FDA, during its review of its marketing application for Viaskin Peanut, has identifi

Gainers Moleculin Biotech, Inc. (NASDAQ: MBRX) shares rose 83% to $0.73 in pre-market trading after the company signed an agreement with UTMB to test WP1122 on a 'range of...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) …

In a report released yesterday, Derek Archila from Stifel Nicolaus downgraded DBV Technologies SA – American ( DBVT – Research Report ) to Hold , with a price target of $6.00 . The company’s sha

DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has info

Gainers OpGen, Inc. (NASDAQ: OPGN) shares climbed 143% to $4.88 after OpGen announced Curetis, a company it is acquiring, is now offering coronavirus test kits. BioNTech SE (...

Aimmune to rise sharply on DBV Technologies setback, says Piper Sandler Piper Sandler AIMT DBVT

While it may not be enough for some shareholders, we think it is good to see the DBV Technologies S.A. (EPA:DBV) share...

Given the widespread market volatility, some investors are seeking refuge in more defensible stocks. However, this certainly doesn’t apply to every Wall Street observer. A select group remains ready

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DBV Technologies SA - American (DBVT) and Sutro Biopharma